DAPT Duration - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey
Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial
Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease
A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study
A randomized comparison of Coronary Stents according to Short or Prolonged durations of Dual Antiplatelet Therapy in patients with Acute Coronary Syndromes: a pre-specified analysis of the SMART-DATE trial
Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention
Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled Trial

|<<... 5 6 7 8 9 10 11 >>|

Clinical Trial

2014 Dec 4;371(23):2155-66

JOURNAL：N Engl J Med.

Article Link

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents

Mauri L, Kereiakes DJ, DAPT Study Investigators.

3793

Keywords: DAPT duration; coronary artery disease; DES; platelet aggregation; inhibitors; stents; thrombosis

FULL TEXT PDF